Nawashiro Hiroshi, Otani Naoki, Uozumi Youichi, Ooigawa Hidetoshi, Toyooka Terushige, Suzuki Takamoto, Katoh Hiroshi, Tsuzuki Nobusuke, Ohnuki Akira, Shima Katsuji, Shinomiya Nariyoshi, Matsuo Hirotaka, Kanai Yoshikatsu
Department of Neurosurgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan.
Brain Tumor Pathol. 2005;22(2):89-91. doi: 10.1007/s10014-005-0188-z.
L-type amino acid transporter 1 (LAT1), a neutral amino acid transport agent, is essential for the transport of large neutral amino acids. LAT1 also corresponds to tumor-associated gene-1 (TA1), an oncofetal antigen that is expressed primarily in fetal tissues and cancer cells such as glioma cells. We have investigated the expression of the transporter in the human primary glioma tissue from 68 patients. Among these patients, we could see the border zone between tumors and normal bain tissues in 10 patients. By WHO criteria, two of the specimens were diagnosed as grade 2, three as grade 3, and five as grade 4 [glioblastoma multiforme (GBM)]. In 9 of 10 cases, we could identify the infiltrating glioma cells associated with stronger immunoreactivity for LAT1. These tumor cells aggregated around the neurons in the border zone and were often found in the perivascular space. In one GBM case, the tumors seemed to develop expansively and separated from the normal brain with a border of arachnoid membrane. The expression of LAT1 was always higher in infiltrating glioma cells than in cells located in the center of the tumor. These findings suggest that LAT1 is one of the molecular targets for glioma therapy.
L型氨基酸转运体1(LAT1)是一种中性氨基酸转运剂,对大中性氨基酸的转运至关重要。LAT1还对应肿瘤相关基因-1(TA1),一种主要在胎儿组织和癌细胞(如胶质瘤细胞)中表达的癌胚抗原。我们研究了68例患者的原发性胶质瘤组织中该转运体的表达情况。在这些患者中,10例患者可见肿瘤与正常脑组织之间的边界区域。根据世界卫生组织(WHO)标准,其中两份标本被诊断为2级,三份为3级,五份为4级[多形性胶质母细胞瘤(GBM)]。在10例中的9例中,我们能够识别出与LAT1免疫反应性更强相关的浸润性胶质瘤细胞。这些肿瘤细胞聚集在边界区域的神经元周围,且常在血管周围间隙中发现。在1例GBM病例中,肿瘤似乎呈膨胀性生长,并通过蛛网膜膜边界与正常脑部分离。浸润性胶质瘤细胞中LAT1的表达总是高于肿瘤中心的细胞。这些发现表明LAT1是胶质瘤治疗的分子靶点之一。